Examining biology and pharmacology-based hypotheses in the PLATO trial.
Publication
, Journal Article
Becker, RC
Published in: J Thromb Thrombolysis
July 2010
Duke Scholars
Published In
J Thromb Thrombolysis
DOI
EISSN
1573-742X
Publication Date
July 2010
Volume
30
Issue
1
Start / End Page
119 / 120
Location
Netherlands
Related Subject Headings
- Ticagrelor
- Swine
- Receptors, Purinergic P2
- Platelet Aggregation Inhibitors
- Humans
- Erythrocytes
- Embolism
- Dogs
- Clinical Trials as Topic
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2010). Examining biology and pharmacology-based hypotheses in the PLATO trial. J Thromb Thrombolysis, 30(1), 119–120. https://doi.org/10.1007/s11239-010-0475-3
Becker, Richard C. “Examining biology and pharmacology-based hypotheses in the PLATO trial.” J Thromb Thrombolysis 30, no. 1 (July 2010): 119–20. https://doi.org/10.1007/s11239-010-0475-3.
Becker RC. Examining biology and pharmacology-based hypotheses in the PLATO trial. J Thromb Thrombolysis. 2010 Jul;30(1):119–20.
Becker, Richard C. “Examining biology and pharmacology-based hypotheses in the PLATO trial.” J Thromb Thrombolysis, vol. 30, no. 1, July 2010, pp. 119–20. Pubmed, doi:10.1007/s11239-010-0475-3.
Becker RC. Examining biology and pharmacology-based hypotheses in the PLATO trial. J Thromb Thrombolysis. 2010 Jul;30(1):119–120.
Published In
J Thromb Thrombolysis
DOI
EISSN
1573-742X
Publication Date
July 2010
Volume
30
Issue
1
Start / End Page
119 / 120
Location
Netherlands
Related Subject Headings
- Ticagrelor
- Swine
- Receptors, Purinergic P2
- Platelet Aggregation Inhibitors
- Humans
- Erythrocytes
- Embolism
- Dogs
- Clinical Trials as Topic
- Cardiovascular System & Hematology